11 Einträge gefunden

1. Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.

   1. Steuber, Thomas
   2. Vickers, Andrew
   3. Haese, Alexander
   4. Kattan, Michael W
   5. Eastham, James A
   6. Scardino, Peter T
   7. Huland, Hartwig

   2007 - Forschungsinformationssystem des UKE
2. Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.

   1. Steuber, Thomas
   2. Vickers, Andrew J
   3. Serio, Angel M
   4. Vaisanen, Ville
   5. Haese, Alexander
   6. Pettersson, Kim
   7. Eastham, James A

   2007 - Forschungsinformationssystem des UKE
3. Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.

   1. Steuber, Thomas
   2. Vickers, Andrew J
   3. Haese, Alexander
   4. Becker, Charlotte
   5. Pettersson, Kim
   6. Chun, Felix K-H
   7. Kattan, Michael W

   2006 - Forschungsinformationssystem des UKE
4. Enhanced discrimination of benign from malignant prostatic disease by selective measurements of cleaved forms of urokinase receptor in serum.

   1. Piironen, Timo
   2. Haese, Alexander
   3. Huland, Hartwig
   4. Steuber, Thomas
   5. Christensen, Ib Jarle
   6. Brünner, Nils
   7. Danø, Keld

   2006 - Forschungsinformationssystem des UKE
5. Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue.

   1. Steuber, Thomas
   2. Niemela, Pauliina
   3. Haese, Alexander
   4. Pettersson, Kim
   5. Erbersdobler, Andreas
   6. Felix Chun, K-H
   7. Graefen, Markus

   2005 - Forschungsinformationssystem des UKE
6. Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade.

   1. Haese, Alexander
   2. Vaisanen, Ville
   3. Lilja, Hans
   4. Kattan, Michael W
   5. Rittenhouse, Harry G
   6. Pettersson, Kim
   7. Chan, Daniel W

   2005 - Forschungsinformationssystem des UKE
7. Prostate-specific antigen and related isoforms in the diagnosis and management of prostate cancer.

   1. Haese, Alexander
   2. Graefen, Markus
   3. Huland, Hartwig
   4. Lilja, Hans

   2004 - Forschungsinformationssystem des UKE
8. Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies.

   1. Haese, Alexander
   2. Graefen, Markus
   3. Steuber, Thomas
   4. Becker, Charlotte
   5. Noldus, Joachim
   6. Erbersdobler, Andreas
   7. Huland, Edith

   2003 - Forschungsinformationssystem des UKE
9. The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer.

   1. Haese, Alexander
   2. Graefen, Markus
   3. Becker, Charlotte
   4. Noldus, Joachin
   5. Katz, Jared
   6. Cagiannos, Ilias
   7. Kattan, Michael

   2003 - Forschungsinformationssystem des UKE
10. Prediction of tumor heterogeneity in localized prostate cancer.

    1. Huland, Hartwig
    2. Graefen, Markus
    3. Haese, Alexander
    4. Hammerer, Peter G
    5. Palisaar, Juri
    6. Pichlmeier, Uwe
    7. Henke, Rolf-P

    2002 - Forschungsinformationssystem des UKE
11. Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen.

    1. Steuber, Thomas
    2. Nurmikko, Paulina
    3. Haese, Alexander
    4. Pettersson, Kim
    5. Graefen, Markus
    6. Hammerer, Peter
    7. Huland, Hartwig

    2002 - Forschungsinformationssystem des UKE